Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: a pooled analysis of 3 studies.

OBJECTIVE: Long-standing evidence indicates that Alzheimer's disease patients with behavioral symptoms have a worse prognosis and a more rapid disease progression. The current retrospective analysis evaluated the efficacy and safety of memantine in a subpopulation of patients with Alzheimer�...

Fuld beskrivelse

Bibliografiske detaljer
Main Authors:	Wilcock, G, Ballard, C, Cooper, J, Loft, H
Format:	Journal article
Sprog:	English
Udgivet:	2008

Lignende værker

Treatment benefits of memantine in moderately severe to severe Alzheimer's disease patients with behavioural symptoms
af: Wilcock, G, et al.
Udgivet: (2006)

Donepezil and memantine for moderate-to-severe Alzheimer's disease
af: Howard, R, et al.
Udgivet: (2012)

DOMINO-AD protocol: donepezil and memantine in moderate to severe Alzheimer's disease - a multicentre RCT.
af: Jones, R, et al.
Udgivet: (2009)

Acetylcholinesterase inhibitors combined with memantine for moderate to severe Alzheimer's disease: a meta-analysis
af: Dominik Glinz, et al.
Udgivet: (2019-06-01)

Efficacy of Memantine, Donepezil, or Their Association in Moderate-Severe Alzheimer’s Disease: A Review of Clinical Trials
af: Ivana Molino, et al.
Udgivet: (2013-01-01)

The pharmacological treatment of Alzheimer's disease with cholinesterase inhibitors and memantine
af: Wilcock, G
Udgivet: (2007)

Donepezil for the treatment of agitation in Alzheimer's disease.
af: Howard, R, et al.
Udgivet: (2007)

Memantine for the treatment of dementia.
af: Wilcock, G
Udgivet: (2003)

Discontinuing Donepezil or Starting Memantine for Alzheimer's Disease Reply
af: Howard, R, et al.
Udgivet: (2012)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease
af: Schneider, L, et al.
Udgivet: (2011)

Lack of evidence for the efficacy of memantine in mild Alzheimer disease.
af: Schneider, L, et al.
Udgivet: (2011)

The clinical use of memantine
af: Burns, A, et al.
Udgivet: (2005)

Memantine Attenuates Alzheimer's Disease-Like Pathology and Cognitive Impairment.
af: Xiaochuan Wang, et al.
Udgivet: (2015-01-01)

Acute interventions for aggression and agitation in psychosis: study protocol for a systematic review and network meta-analysis
af: Toshi A Furukawa, et al.
Udgivet: (2019-10-01)

A long-term comparison of galantamine and donepezil in the treatment of moderate-to-severe Alzheimer's disease: An intent-to-treat analysis
af: Wilcock, G, et al.
Udgivet: (2003)

Synthesis and Characterization of Memantine-Loaded Niosomes for Enhanced Alzheimer’s Disease Targeting
af: Hasan Turkez, et al.
Udgivet: (2025-02-01)

Neuroprotective effect of liraglutide and memantine in a rat model of Alzheimer’s disease
af: Bakhshwin Duaa M., et al.
Udgivet: (2024-05-01)

The ECT-AD trial for severe treatment-refractory agitation and aggression in advanced dementia: Scientific rationale and study design
af: Georgios Petrides, et al.
Udgivet: (2025-01-01)

Memantine and cholinesterase inhibitor combination therapy for Alzheimer's disease: a systematic review
af: Farrimond, L, et al.
Udgivet: (2012)

Prevalence and correlates of aggressive behaviours occurring in patients with Alzheimer's disease.
af: Eastley, R, et al.
Udgivet: (1997)

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).
af: Wilcock, G, et al.
Udgivet: (2002)

Challenges and proposed solutions to conducting Alzheimer’s disease psychosis trials
af: Clive Ballard, et al.
Udgivet: (2024-05-01)

Clozapine to treat aggression and agitation in advanced dementia
af: A. E. Michael, et al.
Udgivet: (2024-04-01)

Neurobiological alteration in agitation in Alzheimer’s disease and possible interventions
af: Jagadeesh S. Rao, et al.
Udgivet: (2024-07-01)

Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).
af: Ballard, C, et al.
Udgivet: (2009)

Memantine for dementia.
af: Mcshane, R, et al.
Udgivet: (2006)

Long term effect of fluoxetine and memantine on biochemical markers of Alzheimer’s disease in scopolamine-induced mice
af: N. N. H. Istifo, et al.
Udgivet: (2023-12-01)

Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients
af: Ehsan Yaghmaei, et al.
Udgivet: (2024-05-01)

Comparing IM Lorazepam and IM Clothiapine for Agitated Psychosis in Hospitalized Patients
af: •. Kverashvili, et al.
Udgivet: (2024-04-01)

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.
af: Wilcock, G, et al.
Udgivet: (1982)

Genetic associations with psychosis and affective disturbance in Alzheimer's disease
af: Inga Margret Antonsdottir, et al.
Udgivet: (2024-04-01)

Current situation and prospect of non-drug treatment of agitated symptoms of Alzheimer disease
af: Zhenfang DONG, et al.
Udgivet: (2024-10-01)

Memantine's Role in Refractory Catatonia
af: Jack Mariani, et al.
Udgivet: (2024-11-01)

The use of memantine for depressive symptomatology
af: J. T. Coelho, et al.
Udgivet: (2024-04-01)

Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia
af: Emma D. Frost, et al.
Udgivet: (2024-11-01)

THE RELATIONSHIP OF ARGYROPHILIC PLAQUES AND NEUROFIBRILLARY TANGLES TO THE SEVERITY OF DEMENTIA AND CORTICAL CHOLINE ACETYL TRANSFERASE LEVELS IN ALZHEIMERS-DISEASE
af: Wilcock, G, et al.
Udgivet: (1983)

DAILY VARIATIONS IN SLEEP-WAKE PATTERNS AND SEVERITY OF PSYCHOSIS
af: Waters, F, et al.
Udgivet: (2010)

Ketamine for rapid control of hyperactive delirium with severe agitation. A retrospective comparison study
af: Beatrice Borreani, et al.
Udgivet: (2025-03-01)

Healthcare Resource Utilization Among Patients With Agitation in Alzheimer Dementia
af: Christie Teigland, et al.
Udgivet: (2024-10-01)

Development and Validation of a Simple UV–HPLC Method to Quantify the Memantine Drug Used in Alzheimer’s Treatment
af: Débora Nunes, et al.
Udgivet: (2024-09-01)